Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhi-Man Zhu

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
International Journal of Biological Sciences|May 14, 2020
Function and evolution of RNA N6-methyladenosine modificationZhi-Man Zhu, Fu-Chun Huo, Dong-Sheng Pei
Investigational New Drugs|July 12, 2021
The biological function of IGF2BPs and their role in tumorigenesisQiu-Ying Du, Zhi-Man Zhu, Dong-Sheng Pei
Cell Proliferation|October 8, 2020
N<sup>6</sup> -methyladenosine (m<sup>6</sup>A) RNA modification in human cancerFu-Chun Huo, Zhi-Man Zhu, Dong-Sheng Pei
Clinical and Translational Medicine|September 29, 2021
PAK5-stabilized Smuc confers renal cell carcinoma metastasisFu-Chun Huo, Zhi-Man Zhu, Qiu-Ying Du, et al.
Genomics|July 7, 2022
SHMT2 promotes the tumorigenesis of renal cell carcinoma by regulating the m6A modification of PPATFu-Chun Huo, Min Xie, Zhi-Man Zhu, et al.
Clinical and Translational Medicine|October 18, 2023
Crosstalk between m6A modification and alternative splicing during cancer progressionZhi-Man Zhu, Fu-Chun Huo, Jian Zhang, et al.
Acta Pharmacologica Sinica|April 24, 2023
COPS6 promotes tumor progression and reduces CD8<sup>+</sup> T cell infiltration by repressing IL-6 production to facilitate tumor immune evasion in breast cancerWen-Qi Du, Zhi-Man Zhu, Xin Jiang, et al.
Oncogene|March 24, 2021
METTL3-mediated m<sup>6</sup>A methylation of SPHK2 promotes gastric cancer progression by targeting KLF2Fu-Chun Huo, Zhi-Man Zhu, Wen-Tao Zhu, et al.
International Journal of Biological Macromolecules|April 7, 2025
METTL3-mediated m6A modification of PAK6 drives cervical cancer progression through activating MAPK14Zhi-Man Zhu, Fu-Chun Huo, Ce Shi, et al.
Pharmacological Research|July 22, 2023
HPV E7-drived ALKBH5 promotes cervical cancer progression by modulating m6A modification of PAK5Fu-Chun Huo, Zhi-Man Zhu, Wen-Qi Du, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
International Journal of Biological Sciences|May 14, 2020
Function and evolution of RNA N6-methyladenosine modificationZhi-Man Zhu, Fu-Chun Huo, Dong-Sheng Pei
Investigational New Drugs|July 12, 2021
The biological function of IGF2BPs and their role in tumorigenesisQiu-Ying Du, Zhi-Man Zhu, Dong-Sheng Pei
Cell Proliferation|October 8, 2020
N<sup>6</sup> -methyladenosine (m<sup>6</sup>A) RNA modification in human cancerFu-Chun Huo, Zhi-Man Zhu, Dong-Sheng Pei
Clinical and Translational Medicine|September 29, 2021
PAK5-stabilized Smuc confers renal cell carcinoma metastasisFu-Chun Huo, Zhi-Man Zhu, Qiu-Ying Du, et al.
Genomics|July 7, 2022
SHMT2 promotes the tumorigenesis of renal cell carcinoma by regulating the m6A modification of PPATFu-Chun Huo, Min Xie, Zhi-Man Zhu, et al.
Clinical and Translational Medicine|October 18, 2023
Crosstalk between m6A modification and alternative splicing during cancer progressionZhi-Man Zhu, Fu-Chun Huo, Jian Zhang, et al.
Acta Pharmacologica Sinica|April 24, 2023
COPS6 promotes tumor progression and reduces CD8<sup>+</sup> T cell infiltration by repressing IL-6 production to facilitate tumor immune evasion in breast cancerWen-Qi Du, Zhi-Man Zhu, Xin Jiang, et al.
Oncogene|March 24, 2021
METTL3-mediated m<sup>6</sup>A methylation of SPHK2 promotes gastric cancer progression by targeting KLF2Fu-Chun Huo, Zhi-Man Zhu, Wen-Tao Zhu, et al.
International Journal of Biological Macromolecules|April 7, 2025
METTL3-mediated m6A modification of PAK6 drives cervical cancer progression through activating MAPK14Zhi-Man Zhu, Fu-Chun Huo, Ce Shi, et al.
Pharmacological Research|July 22, 2023
HPV E7-drived ALKBH5 promotes cervical cancer progression by modulating m6A modification of PAK5Fu-Chun Huo, Zhi-Man Zhu, Wen-Qi Du, et al.
Pageof 1